News US reports its first fatal case of H5N1 bird flu A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.
News UK public urged to take up flu jabs as cases surge The NHS is dealing with a major rise in influenza cases, with the number of hospitalised patients quadrupling to around 5,000 ahead of the New Year.
News Sanofi takes SK Bio-partnered pneumococcal shot into phase 3 Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.
News NIH abandons trial of SIGA's mpox drug Another clinical trial has found that SIGA Technologies' antiviral drug TPOXX (tecovirimat) is ineffective as a treatment for mpox.
News A single mutation could make H5N1 flu a human threat A single mutation in the H5N1 strain of avian influenza that is infecting cows in the US could make it more likely to infect humans, warn researchers.
News Pfizer gets a leg up in RSV as FDA clears jab for all adults A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival shots from GSK and Moderna, but it may not make much of a difference
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
